Institutional Investors Increase Stakes in Teva Pharma and Teradyne

Bessemer Group Inc. raised its holding in Teva Pharmaceutical Industries Ltd. by 1.6% in the first quarter, bringing its stake to 0.38% (4.35 million shares) valued at roughly $131 million. Other investors such as Aster Capital Management, Allworth Financial, Grove Bank & Trust, EverSource Wealth Advisors and Caitong International also adjusted their positions in Teva during the previous quarter.

Watershed Asset Management L.L.C. purchased a new position in Teradyne Inc., acquiring 8,900 shares worth about $2.6 million, which represents 2.7% of its portfolio. Larger shareholders like State Street Corp, Ameriprise Financial, Price T. Rowe Associates and Invesco Ltd. also reported changes to their Teradyne holdings in recent quarters, with institutional investors collectively owning nearly all of the company’s stock.